1-3 of 3
John Francis Seymour, MBBS PhD
Close
Sort by
Journal Articles

Improved Relapse Free Survival Is Predicted by a Negative Pre-Transplant FDG-PET Scan Following Salvage Chemotherapy for Relapsed Diffuse Large B Cell Lymphoma (DLBCL) Treated with Autologous Stem Cell Transplantation.

Michael J. Dickinson, MBBS, Rosemary Hoyt, BN, Andrew Roberts, MBBS PhD, Andrew Grigg, MBBS, John Francis Seymour, MBBS PhD, Jeff Szer, MBBS BSc BMedSci, H. Miles Prince, MBBS(Hons)MD, David Ritchie, MBChB PhD
Journal: Blood
Blood (2007) 110 (11): 5115.
https://doi.org/10.1182/blood.V110.11.5115.5115
Published: 2007
Journal Articles

Prolonged Hematologic Toxicity from the Hyper-CVAD Regimen; Manifestations, Frequency, and Natural History in a Cohort of 125 Consecutive Patients.

Saar Gill, MBBS, Steven Lane, MBBS, Julie Crawford, MBBS, Peter Mollee, MBBS, Paula Marlton, MBBS, Gavin Cull, MBBS, Miles Prince, MBBS, MD, John Francis Seymour, MBBS, PhD
Journal: Blood
Blood (2006) 108 (11): 2441.
https://doi.org/10.1182/blood.V108.11.2441.2441
Published: 2006
Journal Articles

Two Year Data from a Prospective Safety Study Analyzing the Consequences of Imatinib Mesylate Inhibition of Sensitive Kinases Other Than bcr-abl in Patients with Previously Untreated Chronic Phase CML.

John Francis Seymour, MBBS, PhD, Andrew Grigg, MB BS, John Reynolds, Ph D, Anthony P. Schwarer, MB BS PhD, Richard Hermann, MB BS, Kerry McDonald Taylor, MB BS, Kenneth Francis Bradstock, MB BS PhD, Anthony K. Mills, MB BS, Rachel Koelmeyer, BSc, Kevin Lynch, Timothy Hughes, MBBS MD
Journal: Blood
Blood (2006) 108 (11): 2147.
https://doi.org/10.1182/blood.V108.11.2147.2147
Published: 2006